Evidence map›Paper›PMID 28983683›Full record

ArticleClinical neuroradiology2019

In vivo Metabolic Profiles as Determined by

Katharina J Wenger, Elke Hattingen, Kea Franz, Joachim Steinbach, Oliver Bähr, Ulrich Pilatus

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical neuroradiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Optimized Long-TEJournal of magnetic resonance imaging : JMRI · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. PCA denoising and Wiener deconvolution ofMagnetic resonance in medicine · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Lower Lactate Levels and Lower Intracellular pH in Patients withAJNR. American journal of neuroradiology · 2020
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Katharina J WengerDr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
Elke HattingenInstitute of Neuroradiology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany. elke.hattingen@ukbonn.de.ORCID http://orcid.org/0000-0002-8392-9004
Kea FranzDepartment of Neurosurgery, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
Joachim SteinbachDr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
Oliver BährDr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
Ulrich PilatusInstitute of Neuroradiology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
Goethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePrevious ex vivo spectroscopic data from tissue samples revealed differences in phospholipid metabolites between isocitrate dehydrogenase mutated (IDHmut) and IDH wildtype (IDHwt) gliomas. We investigated whether these changes can be found in vivo using

methodsThe study included 33 prospectively enrolled, mostly untreated patients who met spectral quality criteria according to the World Health Organization (WHO II n = 7, WHO III n = 17, WHO IV n = 9; 25 patients IDHmut, 8 patients IDHwt). The MRSI protocol included

resultsIn our patient cohort we did not find significant differences for the ratio of phosphocholine (PC) and phosphoethanolamine (PE), PC/PE, (p = 0.24) for IDHmut compared to IDHwt gliomas. Furthermore, we found no elevated ratios of glycerophosphocholine (GPC) and glycerophosphoethanolamine (GPE), GPC/GPE, (p = 0.68) or GPC/PE (p = 0.12) for IDHmut gliomas. Even the ratio (PC+GPC)/(PE+GPE) showed no significant differences with respect to mutation status (p = 0.16). Nonetheless, changes related to tumor grade regarding intracellular pH (pH

conclusionUsing 3D-CSI data acquisition, in vivo

Indexed as

AdultAgedAnalysis of VarianceAstrocytomaBiomarkers, TumorBrain NeoplasmsDiagnosis, DifferentialEthanolaminesFemaleGlioblastomaGliomaGlutaratesGlycerylphosphorylcholineHumansHydrogenIsocitrate Dehydrogenasealpha-hydroxyglutarateBiomarkers, TumorEthanolaminesGlutaratesglycerophosphoethanolamineGlycerylphosphorylcholineHydrogenIsocitrate DehydrogenaseIsoenzymesPhosphatidylethanolaminesPhosphorus IsotopesPhosphorylcholinephosphorylethanolamineGliomaIDH1 and IDH2 genesIndirect detectionMR SpectroscopyMutations

Identifiers

PMID28983683
OpenAlexW2761865063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.